Cite
MLA Citation
E. Jabbour et al.. “PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY.” HemaSphere, vol. 6, n.d., pp. 1643–1644. http://access.bl.uk/ark:/81055/vdc_100159756069.0x00000a